Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis
Amar U Kishan(University of California, Los Angeles), Daniel E Spratt(University Hospitals Seidman Cancer Center), Kekoa Taparra(Los Angeles County Department of Public Health), Wendy Seiferheld(RTOG Foundation), H. Sandler(Cedars-Sinai Medical Center), J GARCIA(University Hospitals Seidman Cancer Center), Angela Y. Jia(University Hospitals Seidman Cancer Center), Luca Valle(University of California, Los Angeles), Ting Martin(University of Washington), Matthew B. Rettig(University of Southern California), Yilun Sun(Cornell University), Jason A. Efstathiou(Massachusetts General Hospital), Sylvie Chabaud(Centre de Recherche en Cancérologie de Lyon), Meryem Brihoum(UniCancer Group), Matthew R. Sydes(MRC Clinical Trials Unit at UCL), Wayne Brisbane(University of California, Los Angeles), Michael L. Steinberg(University of California, Los Angeles), Soumyajit Roy(Indian Institute of Science Education and Research Kolkata), J. Dignam(NRG Oncology), Adam Singer(University of California, Los Angeles), Tahmineh Romero Kalbasi(University of California, Los Angeles), Scott Eggener(University of California, Los Angeles), A. Pollack(Sylvester Comprehensive Cancer Center), Jonathan E Shoag(University Hospitals Seidman Cancer Center), Nicholas G Nickols(University of California, Los Angeles), Pascal Pommier(Centre Léon Bérard), Paul L Nguyen(Brigham and Women's Hospital), Paul Sargos(Institut Bergonié), Robert E Reiter(University of California, Los Angeles), Nicholas G Zaorsky(University Hospitals Seidman Cancer Center), J. Brown(University Hospitals Seidman Cancer Center), Christopher C Parker(Royal Marsden NHS Foundation Trust), Osama Mohamad(The University of Texas MD Anderson Cancer Center)
Cited by 5
Related Papers
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
|New England Journal of Medicine|2017|1.8k
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|656
Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers
|Angewandte Chemie International Edition|2011|618